Analysts at Nuvama Research said key findings show five times more illness versus the average of the last five years, eight times more hospital visits, and 3.5 times more deaths this season in the US.
Indian companies stand to gain as a result of a strong flu season as they enjoy a one-third share of the total prescription market in Oseltamivir (flu medicine) suspension market.
Oseltamivir is the first-line treatment for Influenza A and B. This has been a generic drug since December 2016 (capsules) and December 2017 (suspension) with multiple players.
Analysts say the number of flu patients and resultant prescriptions has risen in the past two weeks.
This story is from the December 03, 2022 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 03, 2022 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Suffering from lifestyle diseases? It's in the gut
Findings based on research conducted by microbiome-based company Leucine Rich Bio using its flagship technology BugSpeaks
BULLS TO DANCE ON D-STREET DESPITE HEADWINDS
Top-performing stocks across sectors may rise 20-40% over the next year, driven by earnings growth and bullishness on Dalal Street.
Investors in longer-duration debt funds need to be patient
Experts say while rate cuts remain on the table, their start is likely to be delayed
Predictions of normal rains a fillip for agrochem firms
Domestic companies may outperform exporters in March quarter and in FY25
Long runway of growth for AMCS
THE COMPASS Asset management companies are likely to report strong PAT growth in Q4FY24 on the back of AUM growth
IIFL Finance board clears rights issue to raise ₹1,272 cr
The board of IIFL Finance has approved a rights issue in the ratio of one equity share for every nine equity shares amid the continued ban on its gold loan business.
Asian mkts slip as Fed dithers on rate cuts
Asian stocks edged lower following hawkish comments by US Federal Reserve Chair Jerome Powell that helped fuel a third straight drop in the S&P 500 and saw two-year Treasury yields briefly climb to 5 per cent.
Global funds retreat from Asia's EMs
Global funds are retreating from emerging markets in Asia, with a five-month buying spree of stocks ending on scaled-down expectations for US rate cuts.
Advance-decline ratio set for best showing in a year
The advance-decline ratio (ADR), a barometer for overall market sentiment, has improved sharply this month amid a broad-based recovery in stock prices from their lows in March.
Modest rise in net SIP inflows as redemptions jump 54%
Net SIP inflows up 4.9%, even as gross collections rise 28%
